Millendo Therapeutics, Inc.·4

Dec 11, 7:39 PM ET

GILLIS JONATHAN 4

4 · Millendo Therapeutics, Inc. · Filed Dec 11, 2018

Insider Transaction Report

Form 4
Period: 2018-12-07
GILLIS JONATHAN
Vice President Finance
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-05-10+5,0005,000 total
    Exercise: $13.98Exp: 2028-05-10Common Stock (5,000 underlying)
Footnotes (2)
  • [F1]Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.
  • [F2]The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause).

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION